Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients

par Hasinika K. A. H. Gamage, Carola Venturini, Sasha G. Tetu, Masrura Kabir, Vineet Nayyar, Andrew N. Ginn, Belinda Roychoudhry, Lee Thomas, Mitchell Brown, Andrew Holmes, Sally R. Partridge, Ian Seppelt, Ian T. Paulsen, Jonathan R. Iredell
Publié 2021